Clinical trial
RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients
NCT00480350 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00480350 |
|---|---|
| Title | RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral |
| Interventions | rice based food supplement |
| Enrollment | 140 |
| Start date | Sep 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | May 30, 2007 |
| Last update posted | Sep 5, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: